J2353 – Injection, octreotide, depot form for intramuscular injection, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2353
- Long description
- Injection, octreotide, depot form for intramuscular injection, 1 mg
- Short description
- Octreotide injection, depot
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2004
- Last change
- January 1, 2004 – No change
Frequently asked questions
What is HCPCS code J2353?
J2353 is a HCPCS Level II code for injection, octreotide, depot form for intramuscular injection, 1 mg.
Does Medicare cover J2353?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2320 – Injection, nandrolone decanoate, up to 50 mg
- J2323 – Injection, natalizumab, 1 mg
- J2325 – Injection, nesiritide, 0.1 mg
- J2326 – Injection, nusinersen, 0.1 mg
- J2327 – Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329 – Injection, ublituximab-xiiy, 1mg
- J2350 – Injection, ocrelizumab, 1 mg
- J2351 – Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
- J2354 – Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355 – Injection, oprelvekin, 5 mg
- J2356 – Injection, tezepelumab-ekko, 1 mg
- J2357 – Injection, omalizumab, 5 mg
- J2358 – Injection, olanzapine, long-acting, 1 mg
- J2359 – Injection, olanzapine, 0.5 mg
- J2360 – Injection, orphenadrine citrate, up to 60 mg
- J2361 – Injection, depemokimab-ulaa, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.